- Home
- BNTX vs AVB Comparison
BNTX vs AVB Comparison
Compare BNTX & AVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | AVB |
|---|---|---|
| Founded | 2008 | 1978 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 22.5B |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BNTX | AVB |
|---|---|---|
| Price | $97.45 | $168.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 15 |
| Target Price | $133.46 | ★ $198.20 |
| AVG Volume (30 Days) | 807.1K | ★ 942.0K |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.40 |
| Revenue | N/A | ★ $3,040,725,000.00 |
| Revenue This Year | N/A | $4.04 |
| Revenue Next Year | $4.98 | $5.03 |
| P/E Ratio | ★ N/A | $22.96 |
| Revenue Growth | N/A | ★ 4.36 |
| 52 Week Low | $79.81 | $160.10 |
| 52 Week High | $124.00 | $213.34 |
Technical Indicators
Market Signals| Indicator | BNTX | AVB |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 51.35 |
| Support Level | $95.13 | $167.78 |
| Resistance Level | $114.06 | $181.72 |
| Average True Range (ATR) | 2.41 | 2.79 |
| MACD | 1.58 | 1.07 |
| Stochastic Oscillator | 94.42 | 80.93 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 296 apartment communities with more than 90,000 units and is developing 24 additional properties with approximately 8,600 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.